Asahi Kasei Pharma Selects Evotec as Its Partner for Ion Channel Drug Discovery
Virginia Bio Announces THRiVE 2015 Bioscience Conference Featuring Governor Terry McAuliffe
Kolltan Pharmaceuticals to Present at the 2015 American Association for Cancer Research (AACR) Annual Meeting
Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation of AmiKet
Week ending April 27: Quarterly earnings continue to boost market's spirits.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
Three ways to separate long-term winners from stocks that fizzle.
Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...